Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 96 | 2024 | 1079 | 12.850 |
Why?
|
Prostatic Neoplasms | 107 | 2024 | 11122 | 4.660 |
Why?
|
Androgen Receptor Antagonists | 19 | 2022 | 125 | 3.240 |
Why?
|
Androgens | 34 | 2023 | 1286 | 2.210 |
Why?
|
Antigens, CD1 | 44 | 2010 | 439 | 2.070 |
Why?
|
Androgen Antagonists | 26 | 2022 | 1410 | 1.860 |
Why?
|
Natural Killer T-Cells | 8 | 2022 | 322 | 1.840 |
Why?
|
Gene Expression Regulation, Neoplastic | 43 | 2024 | 8554 | 1.700 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 22 | 2014 | 799 | 1.430 |
Why?
|
Neoplasms, Hormone-Dependent | 12 | 2013 | 410 | 1.340 |
Why?
|
Androstenes | 14 | 2021 | 181 | 1.310 |
Why?
|
Cell Line, Tumor | 67 | 2024 | 16990 | 1.270 |
Why?
|
T-Lymphocyte Subsets | 27 | 2017 | 1802 | 1.220 |
Why?
|
Drug Resistance, Neoplasm | 18 | 2021 | 5305 | 1.190 |
Why?
|
Protein Phosphatase 1 | 4 | 2017 | 134 | 1.070 |
Why?
|
Antigens, CD1d | 23 | 2017 | 228 | 1.030 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 2 | 2023 | 43 | 1.010 |
Why?
|
Transcription, Genetic | 26 | 2024 | 7593 | 0.980 |
Why?
|
Chromatin | 11 | 2024 | 2961 | 0.950 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2024 | 3605 | 0.920 |
Why?
|
Protein-Tyrosine Kinases | 8 | 2018 | 2425 | 0.910 |
Why?
|
Phenylthiohydantoin | 8 | 2018 | 205 | 0.900 |
Why?
|
Histone Demethylases | 4 | 2023 | 323 | 0.890 |
Why?
|
Steroid 17-alpha-Hydroxylase | 7 | 2018 | 99 | 0.870 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2024 | 2457 | 0.840 |
Why?
|
Nitriles | 16 | 2018 | 971 | 0.800 |
Why?
|
Oncogene Protein p55(v-myc) | 1 | 2021 | 5 | 0.800 |
Why?
|
Anilides | 9 | 2017 | 411 | 0.750 |
Why?
|
Antineoplastic Agents, Hormonal | 13 | 2021 | 1520 | 0.750 |
Why?
|
Dihydrotestosterone | 11 | 2013 | 195 | 0.720 |
Why?
|
Killer Cells, Natural | 24 | 2010 | 2201 | 0.710 |
Why?
|
Enhancer Elements, Genetic | 5 | 2021 | 1363 | 0.710 |
Why?
|
Down-Regulation | 9 | 2018 | 2919 | 0.700 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 1406 | 0.680 |
Why?
|
Alternative Splicing | 5 | 2024 | 1093 | 0.680 |
Why?
|
Prostate | 16 | 2021 | 1773 | 0.680 |
Why?
|
Male | 164 | 2024 | 360846 | 0.660 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 946 | 0.660 |
Why?
|
Cyclin-Dependent Kinase 9 | 4 | 2024 | 67 | 0.650 |
Why?
|
T-Lymphocytes | 29 | 2014 | 10194 | 0.640 |
Why?
|
Neoplasm Proteins | 9 | 2024 | 3617 | 0.630 |
Why?
|
Mifepristone | 3 | 2008 | 151 | 0.630 |
Why?
|
Repressor Proteins | 7 | 2021 | 2986 | 0.630 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2024 | 1321 | 0.620 |
Why?
|
Prostate-Specific Antigen | 19 | 2021 | 2469 | 0.620 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2018 | 91 | 0.620 |
Why?
|
Androstenols | 3 | 2014 | 25 | 0.610 |
Why?
|
Tosyl Compounds | 8 | 2013 | 115 | 0.600 |
Why?
|
Cell Proliferation | 22 | 2024 | 10451 | 0.590 |
Why?
|
Lymphocyte Activation | 24 | 2022 | 5485 | 0.590 |
Why?
|
Enzyme Activation | 7 | 2013 | 3597 | 0.580 |
Why?
|
PTEN Phosphohydrolase | 7 | 2017 | 1115 | 0.580 |
Why?
|
Cardiovirus Infections | 4 | 2009 | 20 | 0.580 |
Why?
|
Intestinal Mucosa | 15 | 2007 | 3032 | 0.570 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2017 | 42 | 0.570 |
Why?
|
Signal Transduction | 24 | 2024 | 23447 | 0.560 |
Why?
|
Phosphorylation | 14 | 2023 | 8321 | 0.540 |
Why?
|
Humans | 230 | 2024 | 761596 | 0.530 |
Why?
|
Taxoids | 2 | 2020 | 668 | 0.530 |
Why?
|
Receptors, Antigen, T-Cell | 10 | 2017 | 2547 | 0.520 |
Why?
|
Protein Kinase Inhibitors | 9 | 2024 | 5672 | 0.510 |
Why?
|
Mice, SCID | 12 | 2020 | 2626 | 0.500 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3449 | 0.490 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2020 | 1899 | 0.480 |
Why?
|
Nuclear Proteins | 9 | 2023 | 5799 | 0.480 |
Why?
|
Azasteroids | 4 | 2014 | 37 | 0.480 |
Why?
|
CDC2 Protein Kinase | 3 | 2017 | 213 | 0.480 |
Why?
|
Antineoplastic Agents | 12 | 2021 | 13642 | 0.480 |
Why?
|
Galactosylceramides | 7 | 2022 | 92 | 0.470 |
Why?
|
Phosphotyrosine | 2 | 2013 | 456 | 0.470 |
Why?
|
GATA2 Transcription Factor | 1 | 2015 | 158 | 0.470 |
Why?
|
Transfection | 21 | 2014 | 5774 | 0.470 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2013 | 1626 | 0.470 |
Why?
|
Mice | 76 | 2024 | 81539 | 0.460 |
Why?
|
Animals | 103 | 2024 | 168475 | 0.460 |
Why?
|
Castration | 6 | 2022 | 151 | 0.460 |
Why?
|
Progesterone | 5 | 2022 | 742 | 0.460 |
Why?
|
Antigens, CD | 11 | 2010 | 4001 | 0.460 |
Why?
|
Transcriptional Activation | 8 | 2022 | 1756 | 0.450 |
Why?
|
Phosphatidylinositol 3-Kinases | 6 | 2016 | 2865 | 0.450 |
Why?
|
Cytotoxicity, Immunologic | 13 | 2017 | 1351 | 0.440 |
Why?
|
Proto-Oncogene Proteins | 3 | 2024 | 4514 | 0.440 |
Why?
|
Androstadienes | 2 | 2014 | 348 | 0.430 |
Why?
|
Orchiectomy | 7 | 2012 | 463 | 0.430 |
Why?
|
beta Catenin | 6 | 2022 | 1040 | 0.430 |
Why?
|
Cell Culture Techniques | 3 | 2017 | 1668 | 0.420 |
Why?
|
Encephalomyocarditis virus | 2 | 2003 | 21 | 0.420 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 733 | 0.420 |
Why?
|
Ketoconazole | 4 | 2014 | 97 | 0.410 |
Why?
|
SOX9 Transcription Factor | 6 | 2024 | 145 | 0.410 |
Why?
|
DNA-Binding Proteins | 9 | 2020 | 9610 | 0.410 |
Why?
|
Mutant Proteins | 1 | 2014 | 491 | 0.400 |
Why?
|
Disease Progression | 14 | 2019 | 13510 | 0.400 |
Why?
|
Pregnenolone | 1 | 2011 | 27 | 0.390 |
Why?
|
Trans-Activators | 6 | 2013 | 2856 | 0.390 |
Why?
|
p21-Activated Kinases | 4 | 2014 | 128 | 0.380 |
Why?
|
Genes, Tumor Suppressor | 6 | 2022 | 1062 | 0.380 |
Why?
|
Cell Separation | 6 | 2017 | 1720 | 0.380 |
Why?
|
Benzamides | 9 | 2018 | 1371 | 0.380 |
Why?
|
Ubiquitination | 3 | 2024 | 1007 | 0.380 |
Why?
|
Organic Anion Transporters | 3 | 2019 | 101 | 0.380 |
Why?
|
Prednisone | 4 | 2021 | 1563 | 0.360 |
Why?
|
Protein Kinases | 4 | 2008 | 1608 | 0.360 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2021 | 11742 | 0.360 |
Why?
|
Hormone Antagonists | 2 | 2008 | 107 | 0.360 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2022 | 9280 | 0.360 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 4 | 2022 | 164 | 0.350 |
Why?
|
Neoplasm Transplantation | 5 | 2018 | 2016 | 0.350 |
Why?
|
Transcription Factors | 15 | 2023 | 12130 | 0.350 |
Why?
|
Hormones | 2 | 2004 | 869 | 0.340 |
Why?
|
Neoplasms | 9 | 2020 | 22173 | 0.330 |
Why?
|
G1 Phase | 2 | 2012 | 403 | 0.330 |
Why?
|
Protein Binding | 12 | 2020 | 9353 | 0.330 |
Why?
|
Lectins, C-Type | 5 | 2002 | 585 | 0.330 |
Why?
|
Base Sequence | 24 | 2014 | 12441 | 0.320 |
Why?
|
Prostatic Intraepithelial Neoplasia | 2 | 2016 | 81 | 0.320 |
Why?
|
Benzimidazoles | 1 | 2014 | 858 | 0.320 |
Why?
|
Mutation | 17 | 2018 | 30053 | 0.310 |
Why?
|
Bone Marrow Neoplasms | 2 | 1999 | 101 | 0.310 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2013 | 1609 | 0.300 |
Why?
|
Cell Line | 24 | 2021 | 15601 | 0.300 |
Why?
|
Cytoskeletal Proteins | 2 | 2004 | 1342 | 0.300 |
Why?
|
RNA, Messenger | 18 | 2022 | 12794 | 0.300 |
Why?
|
DNA | 6 | 2018 | 7213 | 0.300 |
Why?
|
Testosterone | 12 | 2022 | 2472 | 0.290 |
Why?
|
Interleukin-12 | 5 | 2022 | 584 | 0.280 |
Why?
|
Major Histocompatibility Complex | 6 | 2005 | 870 | 0.280 |
Why?
|
Molecular Sequence Data | 27 | 2008 | 17635 | 0.280 |
Why?
|
Antigens, Surface | 9 | 2002 | 1606 | 0.280 |
Why?
|
Antigen Presentation | 8 | 2010 | 1251 | 0.270 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2016 | 4576 | 0.270 |
Why?
|
Receptor, erbB-3 | 1 | 2007 | 143 | 0.270 |
Why?
|
Leuprolide | 6 | 2017 | 312 | 0.270 |
Why?
|
Mice, Inbred ICR | 5 | 2018 | 364 | 0.270 |
Why?
|
Ligands | 8 | 2021 | 3272 | 0.260 |
Why?
|
Prostatectomy | 9 | 2021 | 1824 | 0.260 |
Why?
|
Peptidylprolyl Isomerase | 1 | 2006 | 97 | 0.260 |
Why?
|
Tumor Cells, Cultured | 13 | 2014 | 6131 | 0.250 |
Why?
|
Apoptosis | 7 | 2024 | 9490 | 0.250 |
Why?
|
Morpholines | 2 | 2008 | 581 | 0.250 |
Why?
|
beta 2-Microglobulin | 7 | 1999 | 329 | 0.250 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2017 | 1860 | 0.240 |
Why?
|
Pyrimidines | 4 | 2024 | 3028 | 0.240 |
Why?
|
Receptor, erbB-2 | 3 | 2016 | 2557 | 0.240 |
Why?
|
Immunotherapy | 4 | 2017 | 4652 | 0.240 |
Why?
|
Pteridines | 1 | 2024 | 47 | 0.240 |
Why?
|
Neuregulin-1 | 2 | 2020 | 135 | 0.240 |
Why?
|
Adenocarcinoma | 4 | 2019 | 6345 | 0.230 |
Why?
|
Retinoblastoma Protein | 4 | 2022 | 672 | 0.230 |
Why?
|
Cell Cycle | 4 | 2013 | 2932 | 0.230 |
Why?
|
Interferon-gamma | 13 | 2017 | 3162 | 0.230 |
Why?
|
Amino Acid Sequence | 20 | 2016 | 13446 | 0.230 |
Why?
|
Chromatography, Liquid | 3 | 2013 | 983 | 0.230 |
Why?
|
Cyclins | 1 | 2006 | 594 | 0.230 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 3713 | 0.230 |
Why?
|
Receptors, Steroid | 1 | 2004 | 156 | 0.230 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 265 | 0.230 |
Why?
|
Point Mutation | 3 | 2004 | 1595 | 0.220 |
Why?
|
Microarray Analysis | 1 | 2006 | 750 | 0.220 |
Why?
|
Membrane Proteins | 2 | 2020 | 7859 | 0.220 |
Why?
|
Intestines | 7 | 1999 | 1910 | 0.220 |
Why?
|
Nuclear Receptor Co-Repressor 1 | 4 | 2008 | 28 | 0.220 |
Why?
|
Protein Isoforms | 7 | 2024 | 1699 | 0.210 |
Why?
|
Neoplasm Metastasis | 9 | 2024 | 4915 | 0.210 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9420 | 0.210 |
Why?
|
Luciferases | 5 | 2008 | 714 | 0.210 |
Why?
|
Molecular Targeted Therapy | 4 | 2019 | 2811 | 0.210 |
Why?
|
Drug Synergism | 2 | 2024 | 1757 | 0.210 |
Why?
|
Neoadjuvant Therapy | 7 | 2021 | 2828 | 0.210 |
Why?
|
Clone Cells | 10 | 2010 | 1659 | 0.200 |
Why?
|
Serine | 3 | 2018 | 831 | 0.200 |
Why?
|
Cell Nucleus | 3 | 2012 | 2910 | 0.200 |
Why?
|
Mediator Complex Subunit 1 | 2 | 2019 | 30 | 0.200 |
Why?
|
Oligonucleotides, Antisense | 2 | 2004 | 461 | 0.200 |
Why?
|
Cytokines | 12 | 2012 | 7396 | 0.200 |
Why?
|
Binding Sites | 10 | 2019 | 6056 | 0.200 |
Why?
|
Immunoblotting | 3 | 2014 | 1646 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2021 | 4580 | 0.200 |
Why?
|
Biopsy | 6 | 2021 | 6766 | 0.200 |
Why?
|
Protein Processing, Post-Translational | 2 | 2024 | 1974 | 0.200 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3878 | 0.200 |
Why?
|
HEK293 Cells | 3 | 2021 | 4281 | 0.190 |
Why?
|
Adiponectin | 1 | 2007 | 1113 | 0.190 |
Why?
|
Hydrocortisone | 1 | 2009 | 1819 | 0.190 |
Why?
|
RNA, Small Interfering | 5 | 2018 | 3430 | 0.190 |
Why?
|
3-Hydroxysteroid Dehydrogenases | 2 | 2014 | 34 | 0.190 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 2 | 2000 | 317 | 0.190 |
Why?
|
Hydroxyprostaglandin Dehydrogenases | 2 | 2014 | 31 | 0.190 |
Why?
|
Carcinoma | 2 | 2011 | 2330 | 0.190 |
Why?
|
Sex Determination Processes | 1 | 2001 | 60 | 0.190 |
Why?
|
Autocrine Communication | 1 | 2022 | 169 | 0.190 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 319 | 0.190 |
Why?
|
Flow Cytometry | 10 | 2017 | 5870 | 0.180 |
Why?
|
Cells, Cultured | 15 | 2020 | 18966 | 0.180 |
Why?
|
Methylation | 2 | 2014 | 1084 | 0.180 |
Why?
|
Antigens, Differentiation | 4 | 1991 | 909 | 0.170 |
Why?
|
Th2 Cells | 3 | 2001 | 1060 | 0.170 |
Why?
|
Dehydroepiandrosterone Sulfate | 3 | 2019 | 241 | 0.170 |
Why?
|
Melanoma | 2 | 2017 | 5709 | 0.170 |
Why?
|
Tissue Array Analysis | 2 | 2019 | 550 | 0.170 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3801 | 0.170 |
Why?
|
Loss of Heterozygosity | 2 | 2019 | 662 | 0.170 |
Why?
|
Serine Endopeptidases | 2 | 2012 | 1023 | 0.170 |
Why?
|
Polymerase Chain Reaction | 12 | 2005 | 6075 | 0.170 |
Why?
|
Protein Structure, Tertiary | 6 | 2012 | 3792 | 0.170 |
Why?
|
Receptor, IGF Type 1 | 2 | 2014 | 380 | 0.170 |
Why?
|
Epithelial-Mesenchymal Transition | 5 | 2024 | 738 | 0.160 |
Why?
|
Prostatic Hyperplasia | 1 | 2023 | 521 | 0.160 |
Why?
|
Mediator Complex | 1 | 2019 | 106 | 0.160 |
Why?
|
Interleukin-4 | 6 | 2017 | 1149 | 0.160 |
Why?
|
Epithelium | 11 | 1997 | 1603 | 0.160 |
Why?
|
Radioactive Pollutants | 1 | 2018 | 13 | 0.160 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2018 | 15 | 0.160 |
Why?
|
Steroid 16-alpha-Hydroxylase | 1 | 2018 | 12 | 0.160 |
Why?
|
Kallikreins | 2 | 2014 | 220 | 0.160 |
Why?
|
Amino Acid Motifs | 2 | 2018 | 931 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2000 | 1435 | 0.150 |
Why?
|
Interleukin-10 | 4 | 2017 | 1175 | 0.150 |
Why?
|
Nuclear Receptor Co-Repressor 2 | 2 | 2008 | 33 | 0.150 |
Why?
|
COS Cells | 5 | 2016 | 1130 | 0.150 |
Why?
|
Growth Inhibitors | 1 | 2019 | 378 | 0.150 |
Why?
|
Antigen-Presenting Cells | 3 | 2011 | 964 | 0.150 |
Why?
|
Up-Regulation | 3 | 2020 | 4125 | 0.150 |
Why?
|
DNA Primers | 6 | 2009 | 2820 | 0.150 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2013 | 2827 | 0.150 |
Why?
|
Adoptive Transfer | 3 | 2017 | 819 | 0.150 |
Why?
|
Imidazolidines | 1 | 1997 | 38 | 0.150 |
Why?
|
5-alpha Reductase Inhibitors | 2 | 2016 | 112 | 0.150 |
Why?
|
Th1 Cells | 6 | 2009 | 1036 | 0.140 |
Why?
|
Environment | 1 | 2023 | 1123 | 0.140 |
Why?
|
Tamoxifen | 1 | 2002 | 965 | 0.140 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2018 | 244 | 0.140 |
Why?
|
Histones | 4 | 2023 | 2580 | 0.140 |
Why?
|
Promoter Regions, Genetic | 6 | 2021 | 5790 | 0.140 |
Why?
|
High Mobility Group Proteins | 2 | 2008 | 177 | 0.140 |
Why?
|
Primary Myelofibrosis | 1 | 2019 | 209 | 0.140 |
Why?
|
Bone Marrow Cells | 2 | 2001 | 2417 | 0.140 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 1015 | 0.140 |
Why?
|
bcl-X Protein | 1 | 2018 | 410 | 0.140 |
Why?
|
Interleukin-2 | 3 | 2017 | 1889 | 0.140 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 2 | 1997 | 67 | 0.140 |
Why?
|
Flutamide | 4 | 2002 | 95 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2917 | 0.130 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 1996 | 64 | 0.130 |
Why?
|
DNA Damage | 3 | 2022 | 2449 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 4 | 2013 | 2467 | 0.130 |
Why?
|
Androstenedione | 2 | 2011 | 131 | 0.130 |
Why?
|
Spleen | 8 | 2012 | 2295 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2017 | 137 | 0.130 |
Why?
|
Cloning, Molecular | 7 | 2002 | 4174 | 0.130 |
Why?
|
Wiskott-Aldrich Syndrome Protein Family | 1 | 2015 | 35 | 0.130 |
Why?
|
Epidermal Growth Factor | 2 | 2009 | 702 | 0.130 |
Why?
|
RNA Splicing | 2 | 2014 | 918 | 0.130 |
Why?
|
Nuclear Receptor Coactivator 1 | 2 | 2007 | 42 | 0.130 |
Why?
|
Cancer Vaccines | 2 | 2022 | 1051 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 2 | 2013 | 1188 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2018 | 1171 | 0.120 |
Why?
|
Aged | 27 | 2021 | 169310 | 0.120 |
Why?
|
RNA Interference | 5 | 2019 | 2832 | 0.120 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 5 | 2002 | 84 | 0.120 |
Why?
|
Genes, MHC Class I | 1 | 1995 | 235 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 454 | 0.120 |
Why?
|
Piperazines | 2 | 2024 | 2523 | 0.120 |
Why?
|
Mice, Nude | 6 | 2020 | 3614 | 0.120 |
Why?
|
Drug Discovery | 2 | 2013 | 1051 | 0.120 |
Why?
|
Mice, Knockout | 12 | 2013 | 14417 | 0.120 |
Why?
|
Feedback, Physiological | 1 | 2017 | 476 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 549 | 0.120 |
Why?
|
Cell Growth Processes | 4 | 2009 | 384 | 0.120 |
Why?
|
Immunity, Innate | 3 | 2017 | 3066 | 0.120 |
Why?
|
Microtubules | 1 | 2020 | 1074 | 0.120 |
Why?
|
TCF Transcription Factors | 2 | 2006 | 138 | 0.120 |
Why?
|
Histone Acetyltransferases | 3 | 2007 | 336 | 0.120 |
Why?
|
Consensus Sequence | 1 | 2014 | 365 | 0.120 |
Why?
|
Transcription Factor 7-Like 2 Protein | 2 | 2006 | 152 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2016 | 318 | 0.110 |
Why?
|
Precipitin Tests | 6 | 1999 | 813 | 0.110 |
Why?
|
Immunohistochemistry | 9 | 2018 | 11076 | 0.110 |
Why?
|
rab1 GTP-Binding Proteins | 1 | 2013 | 5 | 0.110 |
Why?
|
Receptors, IgE | 1 | 1995 | 375 | 0.110 |
Why?
|
Oncogenes | 1 | 1999 | 1222 | 0.110 |
Why?
|
Receptors, Estrogen | 1 | 2002 | 2209 | 0.110 |
Why?
|
Oxygen | 1 | 2005 | 4227 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2822 | 0.110 |
Why?
|
Amino Acid Substitution | 3 | 2012 | 1739 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2009 | 11904 | 0.110 |
Why?
|
Mice, Inbred C57BL | 19 | 2022 | 22174 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 5 | 2011 | 2057 | 0.110 |
Why?
|
Dendritic Cells | 5 | 2008 | 2747 | 0.110 |
Why?
|
Middle Aged | 26 | 2021 | 220921 | 0.110 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 2022 | 891 | 0.110 |
Why?
|
Gene Rearrangement | 3 | 1997 | 1125 | 0.100 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 186 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2020 | 1403 | 0.100 |
Why?
|
Adenine | 1 | 2018 | 987 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 613 | 0.100 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 266 | 0.100 |
Why?
|
Intestine, Small | 2 | 1999 | 1206 | 0.100 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2015 | 504 | 0.100 |
Why?
|
DNA, Neoplasm | 4 | 2012 | 1745 | 0.100 |
Why?
|
Leukocytes | 1 | 2000 | 2026 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6484 | 0.100 |
Why?
|
Peptide Library | 1 | 2013 | 347 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2418 | 0.100 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2013 | 125 | 0.100 |
Why?
|
Pyrazoles | 2 | 2022 | 2009 | 0.100 |
Why?
|
Models, Immunological | 3 | 2011 | 513 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2010 | 1784 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 855 | 0.090 |
Why?
|
DNA, Single-Stranded | 1 | 1993 | 355 | 0.090 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 2017 | 1148 | 0.090 |
Why?
|
MicroRNAs | 3 | 2013 | 3816 | 0.090 |
Why?
|
Histocompatibility Antigens | 2 | 2023 | 464 | 0.090 |
Why?
|
Two-Hybrid System Techniques | 2 | 2002 | 460 | 0.090 |
Why?
|
Indomethacin | 1 | 2011 | 325 | 0.090 |
Why?
|
Epithelial Cells | 10 | 2008 | 3677 | 0.090 |
Why?
|
Genes, Reporter | 3 | 2008 | 1529 | 0.090 |
Why?
|
HeLa Cells | 3 | 2016 | 3094 | 0.090 |
Why?
|
S Phase | 1 | 2012 | 421 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 3 | 1989 | 898 | 0.090 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1993 | 647 | 0.090 |
Why?
|
Dehydroepiandrosterone | 1 | 2011 | 258 | 0.090 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 1903 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2021 | 0.090 |
Why?
|
Doxycycline | 1 | 2012 | 344 | 0.090 |
Why?
|
Sirolimus | 2 | 2008 | 1533 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 1136 | 0.090 |
Why?
|
Antibodies | 1 | 2018 | 2418 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2018 | 1886 | 0.090 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2009 | 21 | 0.090 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2020 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 4 | 2005 | 3733 | 0.090 |
Why?
|
Branched DNA Signal Amplification Assay | 1 | 2009 | 4 | 0.090 |
Why?
|
Fetus | 1 | 1997 | 1863 | 0.090 |
Why?
|
Immunophenotyping | 7 | 2008 | 1869 | 0.090 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2016 | 655 | 0.080 |
Why?
|
Complementarity Determining Regions | 2 | 2008 | 149 | 0.080 |
Why?
|
Piperidines | 1 | 2018 | 1656 | 0.080 |
Why?
|
Thymus Gland | 5 | 2000 | 1243 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2012 | 1229 | 0.080 |
Why?
|
Receptor, Adenosine A2A | 1 | 2010 | 128 | 0.080 |
Why?
|
Immunity, Mucosal | 2 | 2007 | 483 | 0.080 |
Why?
|
Colitis, Ulcerative | 4 | 2001 | 1922 | 0.080 |
Why?
|
Multienzyme Complexes | 2 | 2018 | 666 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2735 | 0.080 |
Why?
|
Oncogene Fusion | 1 | 2009 | 81 | 0.080 |
Why?
|
Receptor, Insulin | 1 | 2013 | 836 | 0.080 |
Why?
|
Biological Evolution | 1 | 1995 | 1071 | 0.080 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2016 | 2748 | 0.080 |
Why?
|
Estrogen Receptor alpha | 2 | 2004 | 583 | 0.080 |
Why?
|
Immune Tolerance | 3 | 2005 | 2302 | 0.080 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 3 | 2007 | 94 | 0.080 |
Why?
|
Blotting, Southern | 2 | 2003 | 777 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 17904 | 0.080 |
Why?
|
Isoleucine | 1 | 2008 | 110 | 0.080 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 4 | 1999 | 1741 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2012 | 719 | 0.080 |
Why?
|
Ukraine | 2 | 2019 | 149 | 0.080 |
Why?
|
Mice, Inbred BALB C | 6 | 2020 | 6214 | 0.080 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 802 | 0.080 |
Why?
|
Monitoring, Immunologic | 1 | 2008 | 98 | 0.080 |
Why?
|
Computational Biology | 3 | 2019 | 3517 | 0.080 |
Why?
|
Pyridines | 2 | 2017 | 2875 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 436 | 0.070 |
Why?
|
Bone Neoplasms | 2 | 2024 | 2529 | 0.070 |
Why?
|
Glucuronosyltransferase | 1 | 2008 | 132 | 0.070 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2001 | 828 | 0.070 |
Why?
|
Wnt Proteins | 3 | 2013 | 718 | 0.070 |
Why?
|
Pyridones | 1 | 2013 | 809 | 0.070 |
Why?
|
Catalytic Domain | 1 | 2010 | 705 | 0.070 |
Why?
|
Blotting, Western | 7 | 2016 | 5035 | 0.070 |
Why?
|
Protein Phosphatase 2 | 1 | 2009 | 231 | 0.070 |
Why?
|
Adenylate Kinase | 1 | 2007 | 102 | 0.070 |
Why?
|
Mutation, Missense | 2 | 2018 | 2571 | 0.070 |
Why?
|
Mass Spectrometry | 2 | 2013 | 2192 | 0.070 |
Why?
|
Antibodies, Monoclonal | 10 | 2009 | 9177 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2014 | 1121 | 0.070 |
Why?
|
Maus Elberfeld virus | 1 | 2006 | 5 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3624 | 0.070 |
Why?
|
Mast-Cell Sarcoma | 3 | 1997 | 46 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2007 | 4369 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2805 | 0.070 |
Why?
|
Cyclin D | 1 | 2006 | 72 | 0.070 |
Why?
|
Genome, Human | 2 | 2017 | 4425 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 1997 | 3701 | 0.070 |
Why?
|
Mammals | 2 | 2002 | 1132 | 0.070 |
Why?
|
Adult | 19 | 2021 | 221210 | 0.070 |
Why?
|
Conserved Sequence | 2 | 2008 | 1163 | 0.070 |
Why?
|
Hydroxysteroid Dehydrogenases | 1 | 2006 | 29 | 0.070 |
Why?
|
Phosphoserine | 1 | 2006 | 203 | 0.070 |
Why?
|
Liver | 7 | 2012 | 7528 | 0.070 |
Why?
|
Testis | 2 | 2017 | 794 | 0.070 |
Why?
|
Immunity, Cellular | 4 | 2007 | 1560 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2006 | 203 | 0.070 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2008 | 350 | 0.070 |
Why?
|
Mice, Transgenic | 7 | 2013 | 9542 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1997 | 4352 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2007 | 309 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2001 | 1349 | 0.060 |
Why?
|
Neoplasms, Experimental | 2 | 2001 | 1229 | 0.060 |
Why?
|
Metabolic Diseases | 1 | 2012 | 683 | 0.060 |
Why?
|
Genes | 2 | 1989 | 1823 | 0.060 |
Why?
|
Treatment Outcome | 11 | 2021 | 64685 | 0.060 |
Why?
|
Cricetinae | 2 | 2007 | 2423 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2006 | 205 | 0.060 |
Why?
|
Cricetulus | 1 | 2007 | 814 | 0.060 |
Why?
|
Lymphocyte Transfusion | 1 | 2006 | 232 | 0.060 |
Why?
|
Antibody Specificity | 3 | 2008 | 1060 | 0.060 |
Why?
|
GTPase-Activating Proteins | 1 | 2008 | 471 | 0.060 |
Why?
|
Adrenal Glands | 2 | 2018 | 552 | 0.060 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2004 | 20 | 0.060 |
Why?
|
Protein Biosynthesis | 2 | 2004 | 2112 | 0.060 |
Why?
|
Serum Response Factor | 1 | 2004 | 78 | 0.060 |
Why?
|
src-Family Kinases | 1 | 2007 | 535 | 0.060 |
Why?
|
Dermatitis, Contact | 1 | 2005 | 133 | 0.060 |
Why?
|
Aged, 80 and over | 9 | 2021 | 58984 | 0.060 |
Why?
|
Hodgkin Disease | 2 | 2008 | 1378 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 678 | 0.060 |
Why?
|
Transgenes | 2 | 2012 | 1010 | 0.060 |
Why?
|
Models, Biological | 3 | 2012 | 9469 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2023 | 35 | 0.060 |
Why?
|
Cyproterone Acetate | 1 | 2003 | 5 | 0.060 |
Why?
|
Gene Expression | 5 | 2017 | 7581 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 615 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1092 | 0.060 |
Why?
|
Sequence Analysis | 2 | 2002 | 240 | 0.060 |
Why?
|
Cell Division | 3 | 2009 | 4465 | 0.050 |
Why?
|
Vitreous Body | 1 | 2005 | 399 | 0.050 |
Why?
|
Protein Transport | 3 | 2019 | 1967 | 0.050 |
Why?
|
Soybean Proteins | 1 | 2003 | 55 | 0.050 |
Why?
|
Sulfonamides | 1 | 2013 | 1979 | 0.050 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2001 | 509 | 0.050 |
Why?
|
Thalidomide | 1 | 2008 | 885 | 0.050 |
Why?
|
Purines | 1 | 2006 | 607 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2006 | 598 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2002 | 68 | 0.050 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2002 | 40 | 0.050 |
Why?
|
Female | 23 | 2019 | 392705 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 2 | 2008 | 3165 | 0.050 |
Why?
|
Bone Marrow | 2 | 2005 | 2911 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2002 | 127 | 0.050 |
Why?
|
Vaccines, Combined | 1 | 2022 | 70 | 0.050 |
Why?
|
Sex-Determining Region Y Protein | 1 | 2001 | 15 | 0.050 |
Why?
|
DAX-1 Orphan Nuclear Receptor | 1 | 2001 | 29 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2005 | 4740 | 0.050 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 1996 | 212 | 0.050 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 858 | 0.050 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1693 | 0.050 |
Why?
|
Quinazolines | 1 | 2008 | 1371 | 0.050 |
Why?
|
Multigene Family | 2 | 1996 | 1076 | 0.050 |
Why?
|
DNA Repair | 2 | 2022 | 2046 | 0.050 |
Why?
|
Models, Molecular | 3 | 2020 | 5439 | 0.050 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21019 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 687 | 0.050 |
Why?
|
Antigens | 3 | 2005 | 1443 | 0.050 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 619 | 0.050 |
Why?
|
rac GTP-Binding Proteins | 1 | 2002 | 162 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3810 | 0.050 |
Why?
|
Histone Deacetylases | 2 | 2003 | 720 | 0.050 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2002 | 187 | 0.050 |
Why?
|
Adrenal Cortex | 1 | 2021 | 134 | 0.050 |
Why?
|
DNA Replication | 2 | 2019 | 1418 | 0.050 |
Why?
|
Immune Sera | 3 | 2001 | 606 | 0.050 |
Why?
|
Cell Membrane | 4 | 1994 | 3687 | 0.050 |
Why?
|
Receptors, Retinoic Acid | 1 | 2001 | 224 | 0.050 |
Why?
|
Cell Communication | 1 | 2008 | 1657 | 0.050 |
Why?
|
Kidney Neoplasms | 2 | 2008 | 4251 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2001 | 178 | 0.050 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1541 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 416 | 0.050 |
Why?
|
Etoposide | 1 | 2002 | 634 | 0.040 |
Why?
|
Glucose Tolerance Test | 1 | 2003 | 1178 | 0.040 |
Why?
|
Adipose Tissue | 1 | 2012 | 3313 | 0.040 |
Why?
|
Neoplasm Invasiveness | 3 | 2016 | 3597 | 0.040 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2008 | 1374 | 0.040 |
Why?
|
Hydrolysis | 1 | 2001 | 664 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2002 | 461 | 0.040 |
Why?
|
Multiple Myeloma | 2 | 2008 | 5146 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2013 | 3514 | 0.040 |
Why?
|
Survival Analysis | 2 | 2017 | 10090 | 0.040 |
Why?
|
Acetyltransferases | 1 | 2001 | 231 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4878 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2021 | 305 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 294 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 1999 | 107 | 0.040 |
Why?
|
Isoxazoles | 1 | 2001 | 232 | 0.040 |
Why?
|
Steroids | 1 | 2004 | 929 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2019 | 178 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2001 | 451 | 0.040 |
Why?
|
Estradiol | 2 | 1997 | 1937 | 0.040 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2023 | 682 | 0.040 |
Why?
|
Lymphocyte Count | 3 | 2012 | 778 | 0.040 |
Why?
|
Progesterone Reductase | 1 | 2018 | 14 | 0.040 |
Why?
|
Steroid Isomerases | 1 | 2018 | 19 | 0.040 |
Why?
|
Lymphocytes | 2 | 1991 | 2612 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2022 | 350 | 0.040 |
Why?
|
Cell Polarity | 2 | 1999 | 636 | 0.040 |
Why?
|
Lysine | 1 | 2023 | 993 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39106 | 0.040 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2018 | 56 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10766 | 0.040 |
Why?
|
Risk | 3 | 2021 | 9610 | 0.040 |
Why?
|
DNA Methylation | 2 | 2024 | 4399 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2022 | 561 | 0.040 |
Why?
|
Glycosylphosphatidylinositols | 1 | 1998 | 90 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1835 | 0.040 |
Why?
|
Myocarditis | 2 | 2006 | 788 | 0.040 |
Why?
|
Tyrosine | 3 | 2012 | 1440 | 0.040 |
Why?
|
Glucuronides | 1 | 2017 | 20 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2023 | 988 | 0.040 |
Why?
|
Calreticulin | 1 | 2018 | 114 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1188 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 1999 | 368 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 346 | 0.040 |
Why?
|
Actins | 2 | 2004 | 2050 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 2000 | 1900 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 412 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2018 | 160 | 0.040 |
Why?
|
Codon | 1 | 1999 | 601 | 0.040 |
Why?
|
Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 1997 | 133 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2011 | 4111 | 0.040 |
Why?
|
Perforin | 1 | 1997 | 167 | 0.040 |
Why?
|
Gene Silencing | 2 | 2014 | 1509 | 0.030 |
Why?
|
Testosterone Congeners | 1 | 2017 | 62 | 0.030 |
Why?
|
Organ Specificity | 1 | 2002 | 1968 | 0.030 |
Why?
|
Medical Oncology | 1 | 2009 | 2321 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 1997 | 216 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2007 | 3080 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 1997 | 1704 | 0.030 |
Why?
|
Common Bile Duct | 1 | 1997 | 106 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1787 | 0.030 |
Why?
|
Molecular Weight | 2 | 1994 | 2186 | 0.030 |
Why?
|
NF-kappa B | 1 | 2005 | 2490 | 0.030 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 1997 | 150 | 0.030 |
Why?
|
Oligopeptides | 1 | 2022 | 1187 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 702 | 0.030 |
Why?
|
Lymphomatoid Papulosis | 1 | 1996 | 16 | 0.030 |
Why?
|
Adrenalectomy | 1 | 2018 | 346 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 2 | 1992 | 531 | 0.030 |
Why?
|
Ovalbumin | 3 | 2005 | 677 | 0.030 |
Why?
|
beta-Galactosidase | 1 | 1997 | 574 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 1994 | 1762 | 0.030 |
Why?
|
Sulfates | 1 | 2017 | 380 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2017 | 15936 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 3 | 2007 | 2422 | 0.030 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2016 | 74 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2007 | 306 | 0.030 |
Why?
|
Monocytes | 1 | 2005 | 2570 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 247 | 0.030 |
Why?
|
Granzymes | 1 | 1997 | 277 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 246 | 0.030 |
Why?
|
Pyrans | 1 | 2016 | 49 | 0.030 |
Why?
|
Cytoskeleton | 1 | 1981 | 1170 | 0.030 |
Why?
|
Spiro Compounds | 1 | 2016 | 68 | 0.030 |
Why?
|
Rabbits | 1 | 2002 | 4772 | 0.030 |
Why?
|
Tubulin | 1 | 2019 | 693 | 0.030 |
Why?
|
Eye | 1 | 1999 | 712 | 0.030 |
Why?
|
Glycosylation | 2 | 1999 | 1097 | 0.030 |
Why?
|
Dietary Fats | 1 | 2003 | 1995 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2557 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2008 | 3397 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 560 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1996 | 1991 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2048 | 0.030 |
Why?
|
Basement Membrane | 1 | 1996 | 349 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1997 | 586 | 0.030 |
Why?
|
Tissue Kallikreins | 1 | 2014 | 14 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2004 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6815 | 0.030 |
Why?
|
Androsterone | 1 | 2013 | 14 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2017 | 428 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 1999 | 504 | 0.030 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2014 | 131 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1218 | 0.030 |
Why?
|
Colitis | 2 | 2000 | 1233 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2811 | 0.030 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1993 | 32 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1996 | 347 | 0.030 |
Why?
|
Interferon-alpha | 2 | 2009 | 921 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1612 | 0.030 |
Why?
|
Phenotype | 4 | 2021 | 16592 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11120 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2095 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
Goserelin | 1 | 2013 | 126 | 0.030 |
Why?
|
Bone Marrow Diseases | 1 | 1995 | 233 | 0.030 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2013 | 135 | 0.030 |
Why?
|
Myristic Acid | 1 | 2012 | 49 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2012 | 87 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 803 | 0.030 |
Why?
|
Blotting, Northern | 1 | 1994 | 1545 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1768 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2014 | 3639 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2012 | 452 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 2 | 2005 | 490 | 0.020 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2012 | 171 | 0.020 |
Why?
|
Genome | 1 | 2020 | 1740 | 0.020 |
Why?
|
Mice, Inbred AKR | 2 | 1981 | 104 | 0.020 |
Why?
|
Binding, Competitive | 2 | 2004 | 1141 | 0.020 |
Why?
|
Hepatitis C | 1 | 2002 | 1584 | 0.020 |
Why?
|
Mice, Obese | 1 | 2012 | 420 | 0.020 |
Why?
|
Protein Kinase C-alpha | 1 | 2011 | 113 | 0.020 |
Why?
|
Operon | 1 | 2012 | 372 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1008 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 203 | 0.020 |
Why?
|
Peptides | 2 | 2008 | 4358 | 0.020 |
Why?
|
Transforming Growth Factor beta | 2 | 2010 | 1964 | 0.020 |
Why?
|
Imidazoles | 1 | 1997 | 1180 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 416 | 0.020 |
Why?
|
Mammary Glands, Animal | 1 | 2013 | 273 | 0.020 |
Why?
|
Cell Survival | 3 | 2011 | 5791 | 0.020 |
Why?
|
Genomic Library | 1 | 1991 | 189 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1996 | 3076 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4615 | 0.020 |
Why?
|
Diverticulitis | 3 | 1999 | 185 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2014 | 1972 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2014 | 790 | 0.020 |
Why?
|
Mice, Inbred DBA | 2 | 1981 | 621 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3612 | 0.020 |
Why?
|
Graft Survival | 1 | 2001 | 3820 | 0.020 |
Why?
|
Pyrazines | 1 | 2016 | 1202 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12947 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 2231 | 0.020 |
Why?
|
Digestive System | 1 | 1990 | 244 | 0.020 |
Why?
|
Genotype | 2 | 2017 | 12990 | 0.020 |
Why?
|
Methyltransferases | 1 | 2012 | 377 | 0.020 |
Why?
|
Antigens, Ly | 2 | 2001 | 295 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7828 | 0.020 |
Why?
|
Cell Death | 2 | 2008 | 1679 | 0.020 |
Why?
|
Jejunum | 1 | 1991 | 472 | 0.020 |
Why?
|
Estrogens | 1 | 1996 | 1522 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 2005 | 2561 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8527 | 0.020 |
Why?
|
DNA Helicases | 1 | 2014 | 851 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4542 | 0.020 |
Why?
|
Pilot Projects | 3 | 2013 | 8633 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 2011 | 449 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2020 | 1853 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1858 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 2008 | 167 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2000 | 3465 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 200 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 29629 | 0.020 |
Why?
|
Proteins | 2 | 2001 | 6032 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1989 | 851 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1994 | 1674 | 0.020 |
Why?
|
Histiocytes | 1 | 1988 | 98 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4021 | 0.020 |
Why?
|
G2 Phase | 1 | 2008 | 136 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23996 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1989 | 1058 | 0.020 |
Why?
|
Solubility | 2 | 1998 | 1091 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2008 | 293 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8466 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2000 | 4758 | 0.020 |
Why?
|
Rats | 2 | 1994 | 23741 | 0.020 |
Why?
|
Biological Transport | 1 | 2011 | 2091 | 0.020 |
Why?
|
Recombination, Genetic | 2 | 1988 | 1519 | 0.020 |
Why?
|
Crohn Disease | 2 | 1996 | 2279 | 0.020 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 1007 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 1993 | 940 | 0.020 |
Why?
|
Cisplatin | 1 | 1992 | 1652 | 0.020 |
Why?
|
Lipopolysaccharides | 2 | 2005 | 2206 | 0.020 |
Why?
|
Lymphoma | 2 | 1988 | 1901 | 0.020 |
Why?
|
Radiation Tolerance | 1 | 2008 | 478 | 0.020 |
Why?
|
Radiography | 1 | 2016 | 6965 | 0.020 |
Why?
|
Twins, Monozygotic | 2 | 1998 | 470 | 0.020 |
Why?
|
Oxazolone | 1 | 2005 | 61 | 0.020 |
Why?
|
Cyclic GMP | 1 | 2006 | 395 | 0.020 |
Why?
|
Diet | 1 | 2003 | 8075 | 0.020 |
Why?
|
Cytoplasm | 2 | 1999 | 1510 | 0.020 |
Why?
|
Diseases in Twins | 2 | 1998 | 446 | 0.020 |
Why?
|
Skin | 2 | 1996 | 4484 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2006 | 326 | 0.020 |
Why?
|
Phosphatidylethanolamines | 1 | 2005 | 129 | 0.020 |
Why?
|
Paralysis | 1 | 2006 | 250 | 0.010 |
Why?
|
Sequence Alignment | 2 | 2001 | 2180 | 0.010 |
Why?
|
Genomics | 1 | 2020 | 5821 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2650 | 0.010 |
Why?
|
Tumor Escape | 1 | 2007 | 370 | 0.010 |
Why?
|
Macrophages | 2 | 2012 | 5767 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3779 | 0.010 |
Why?
|
Glycolipids | 1 | 2005 | 206 | 0.010 |
Why?
|
Bronchi | 1 | 2008 | 845 | 0.010 |
Why?
|
Neutrophils | 1 | 2017 | 3767 | 0.010 |
Why?
|
Molecular Structure | 1 | 2008 | 1880 | 0.010 |
Why?
|
H-2 Antigens | 2 | 2001 | 357 | 0.010 |
Why?
|
Thymine Nucleotides | 1 | 2003 | 57 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10774 | 0.010 |
Why?
|
Reference Values | 2 | 2002 | 4920 | 0.010 |
Why?
|
Chemokine CXCL2 | 1 | 2003 | 106 | 0.010 |
Why?
|
Cysteine | 1 | 2008 | 891 | 0.010 |
Why?
|
Skin Diseases | 1 | 1992 | 1094 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2003 | 123 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2008 | 823 | 0.010 |
Why?
|
Kinetics | 2 | 1981 | 6374 | 0.010 |
Why?
|
Viremia | 1 | 2006 | 707 | 0.010 |
Why?
|
Dermatitis | 1 | 2005 | 202 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1998 | 3415 | 0.010 |
Why?
|
Administration, Topical | 1 | 2005 | 704 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1994 | 8181 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 2003 | 212 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1993 | 4243 | 0.010 |
Why?
|
Decidua | 1 | 2002 | 82 | 0.010 |
Why?
|
Carbohydrate Metabolism | 1 | 2003 | 263 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2004 | 878 | 0.010 |
Why?
|
Chromium Radioisotopes | 1 | 1981 | 34 | 0.010 |
Why?
|
Cell Differentiation | 3 | 2005 | 11530 | 0.010 |
Why?
|
History, 20th Century | 1 | 2010 | 2767 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2002 | 321 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1993 | 1640 | 0.010 |
Why?
|
Uveitis | 1 | 2005 | 395 | 0.010 |
Why?
|
Suspensions | 1 | 1981 | 66 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12973 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 2001 | 114 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1844 | 0.010 |
Why?
|
Cell Adhesion | 2 | 1993 | 3088 | 0.010 |
Why?
|
Membranes | 1 | 1981 | 165 | 0.010 |
Why?
|
Sarcoma, Experimental | 1 | 1981 | 117 | 0.010 |
Why?
|
Acetylation | 1 | 2003 | 1055 | 0.010 |
Why?
|
Trophoblasts | 1 | 2002 | 224 | 0.010 |
Why?
|
U937 Cells | 1 | 2001 | 261 | 0.010 |
Why?
|
Genes, RAG-1 | 1 | 2000 | 67 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2001 | 413 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 2001 | 243 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2001 | 436 | 0.010 |
Why?
|
Detergents | 1 | 1981 | 236 | 0.010 |
Why?
|
p300-CBP Transcription Factors | 1 | 2001 | 150 | 0.010 |
Why?
|
Genes, T-Cell Receptor alpha | 1 | 1999 | 19 | 0.010 |
Why?
|
Anterior Chamber | 1 | 2001 | 194 | 0.010 |
Why?
|
Leukemia | 1 | 1988 | 1522 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 2003 | 561 | 0.010 |
Why?
|
Muscles | 1 | 2004 | 1576 | 0.010 |
Why?
|
Pregnancy | 2 | 2002 | 29890 | 0.010 |
Why?
|
Thymoma | 1 | 1981 | 188 | 0.010 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2001 | 377 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2269 | 0.010 |
Why?
|
Hexosaminidases | 1 | 1999 | 45 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2001 | 740 | 0.010 |
Why?
|
Time Factors | 4 | 2004 | 39969 | 0.010 |
Why?
|
Dextran Sulfate | 1 | 2000 | 256 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1600 | 0.010 |
Why?
|
K562 Cells | 1 | 2001 | 642 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2005 | 1189 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 59260 | 0.010 |
Why?
|
Chemokines | 1 | 2003 | 959 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18255 | 0.010 |
Why?
|
Lymphopenia | 1 | 2001 | 281 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2003 | 774 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 4937 | 0.010 |
Why?
|
Virus Replication | 1 | 2006 | 2435 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 1999 | 279 | 0.010 |
Why?
|
Triplets | 1 | 1998 | 42 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2000 | 750 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1999 | 419 | 0.010 |
Why?
|
Injections | 1 | 2001 | 831 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2645 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2006 | 2136 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 1999 | 562 | 0.010 |
Why?
|
Magnesium | 1 | 1981 | 804 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2001 | 1126 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 2002 | 751 | 0.010 |
Why?
|
CHO Cells | 1 | 1999 | 1387 | 0.010 |
Why?
|
Caco-2 Cells | 1 | 1997 | 364 | 0.010 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1996 | 111 | 0.010 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1998 | 506 | 0.010 |
Why?
|
Gene Amplification | 1 | 2000 | 1089 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1997 | 522 | 0.010 |
Why?
|
Vaccination | 1 | 2008 | 3384 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2005 | 1171 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2005 | 3208 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2003 | 1935 | 0.010 |
Why?
|
Skin Transplantation | 1 | 2001 | 1083 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7237 | 0.010 |
Why?
|
Temperature | 1 | 1981 | 2226 | 0.010 |
Why?
|
Brain | 1 | 2002 | 27121 | 0.010 |
Why?
|
Brachytherapy | 1 | 2002 | 1223 | 0.010 |
Why?
|
Kidney | 2 | 2004 | 7048 | 0.010 |
Why?
|
Retina | 1 | 2005 | 2659 | 0.010 |
Why?
|
Molecular Probes | 1 | 1996 | 309 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2000 | 2510 | 0.010 |
Why?
|
Endocytosis | 1 | 1999 | 957 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2915 | 0.010 |
Why?
|
Lymphoma, T-Cell | 1 | 1997 | 304 | 0.010 |
Why?
|
Mycosis Fungoides | 1 | 1996 | 170 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2002 | 4853 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20100 | 0.010 |
Why?
|
Dogs | 1 | 1999 | 3839 | 0.010 |
Why?
|
Survival Rate | 1 | 2008 | 12723 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1997 | 563 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2005 | 2244 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 1999 | 1971 | 0.010 |
Why?
|
Reed-Sternberg Cells | 1 | 1992 | 72 | 0.010 |
Why?
|
Autoimmunity | 1 | 1999 | 1356 | 0.010 |
Why?
|
RNA | 2 | 1993 | 2725 | 0.010 |
Why?
|
Glycoproteins | 1 | 1999 | 2203 | 0.010 |
Why?
|
Colon | 1 | 1999 | 1792 | 0.010 |
Why?
|
Pain Measurement | 1 | 2001 | 3551 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1996 | 2571 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1992 | 783 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 41495 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1993 | 2264 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4948 | 0.010 |
Why?
|
Cell Movement | 1 | 2001 | 5205 | 0.000 |
Why?
|
Drosophila melanogaster | 1 | 1997 | 1712 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5841 | 0.000 |
Why?
|
Calcium | 1 | 1981 | 5722 | 0.000 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1988 | 817 | 0.000 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1993 | 1492 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 1302 | 0.000 |
Why?
|
Fibroblasts | 1 | 1997 | 4142 | 0.000 |
Why?
|
Glucose | 1 | 1997 | 4347 | 0.000 |
Why?
|
Prevalence | 1 | 2001 | 15733 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1988 | 1386 | 0.000 |
Why?
|
Receptors, Immunologic | 1 | 1988 | 1410 | 0.000 |
Why?
|
Quality of Life | 1 | 2002 | 13367 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1982 | 510 | 0.000 |
Why?
|
Liposomes | 1 | 1982 | 783 | 0.000 |
Why?
|
Skin Neoplasms | 1 | 1996 | 5821 | 0.000 |
Why?
|